Zsolt Faluhelyi

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.

István Kiss, Árpád Németh, Barna Bogner et al. · PubMed · 2005 · 36 citations

[Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms].

Erika Kövér, Zsolt Faluhelyi, Barna Bogner et al. · PubMed · 2004 · 29 citations

Gastroenterology, Pathology, Gi Tract +19

All-trans retinoic acid (ATRA) suppresses transcription of human papillomavirus type 16 (HPV16) in a dose-dependent manner.

Zsolt Faluhelyi, Imre Rodler, András Csejtey et al. · PubMed · 2004 · 24 citations

Immunology, Pathology, All-trans Retinoic Acid +18